Merck & Co., Inc.'s trial balance as of December 31, 2023, is as follows:

Account	Debit ($)	Credit ($)
Cash	2,250,000
Accounts Receivable	4,500,000
Inventory	3,500,000
Equipment	15,500,000
Accumulated Depreciation		9,500,000
Accounts Payable		5,500,000
Notes Payable		15,000,000
Common Stock		14,500,000
Retained Earnings		6,500,000
Sales Revenue		26,500,000
Cost of Goods Sold	16,000,000
Salaries Expense	4,500,000
Rent Expense	2,000,000

Prepare the adjusted trial balance for Merck & Co., Inc. as of December 31, 2023.